An overview of chemoprevention: Current status and future prospects

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 133-141

  Wattenberg, Lee W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CONTRACEPTIVE AGENT; GLUCOCORTICOID; HORMONE ANTAGONIST; OLTIPRAZ; POLYPHENOL DERIVATIVE; PROTEINASE INHIBITOR; RETINOID; RETINOL; SELENIUM DERIVATIVE; SULINDAC; TERPENE; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; ARACHIDONIC ACID METABOLISM; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CANCER; DETOXIFICATION; DRUG MECHANISM; HIGH RISK POPULATION; LUNG CANCER; OVARY CANCER; PROSTATE CANCER; REVIEW;

EID: 0030875366     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44163     Document Type: Review

References (70)

1. Wattenberg LW, Lipkin M, Boone CW, Kelloff GJ, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp630, 1992.
2. Wattenberg LW. Chemoprevention of cancer. Cancer Res 45:1-8, 1985.
3. Wattenberg LW. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg LW, Lipkin M, Boone M, Kelloff GJ, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp19-39, 1992.
4. Wattenberg LW. What are the critical attributes for cancer chemopreventive agents? Ann N Y Acad Sci 768:73-81, 1995.
5. Wattenberg LW. Prevention, therapy and basic science and the resolution of the cancer problem. Cancer Res 53:5890-5896, 1993.
6. Smith AH, Checkoway H, Goldsmith DF, Wolf PH, Tyroler HA. An analytic procedure for investigation of cancer latency in matched case control studies illustrated with occupational data. Am J Epidemiol 108:226-248, 1978.
7. Kennaway EL. The incubation period of cancer in man. In: Raven RW, Ed. Cancer, Vol. 1, London: Butterworth and Company, Vol 1: pp6-23, 1957.
8. Armenian HK, Lilienfeld AM. The distribution of incubation periods of neoplastic diseases. Am J Epidemiol 99;92-100, 1974.
9. Polednak AP. Latency periods in neoplastic diseases. Am J Epidemiol 100:354-356, 1974.
10. Doll R, Peto R. Cigarette smoking, and bronchial carcinoma: Dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 32:303-313, 1978.
11. Peto R. Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ 74:23-33, 1986.
12. Anonymous. Cancer Facts and Figures - 1996. Atlanta, GA: American Cancer Society, pp33, 1996.
13. Wattenberg LW. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg LW, Lipkin M, Boone M, Kelloff GJ, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp19-39, 1992.
14. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52:2085s-2089s, 1992.
15. Wattenberg LW. Chemoprevention of carcinogenesis by minor non-nutrient constituents of the diet. In: Parke DV, Ioannides C, Walker R, Eds. Food, Nutrition and Chemical Toxicity. London: Smith-Gordon, pp287-300, 1993.
16. Kelloff GJ, Boone CW, Malone WF, Crowell JA, Steele VE, Perloff M, Lubet R, Sigman CC. Chemopreventive drug development: Perspectives and progress. Cancer Epidemiol Biomarkers Prev 3:85-98, 1994.
17. Wattenberg LW, Bueding E. Inhibitory effects of 5-(2-pyrazinyl)-4 methyl-2,2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo(a)pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis (Lond) 7:1379-1381, 1986.
18. Kensler TW, Groopman JD, Roebuck BD. Chemoprotection by oltipraz and other dithiolethiones. In: Wattenberg LW, Lipkin M, Boone M, Kelloff GF, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp205-226, 1992.
19. Hochalter JB, Wattenberg LW, Coccia JB, Galbraith AR. Inhibition of β-propiolactone-induced neoplasia of the forestomach and large bowel by 4-mercaptobenzene sulfonate in mice and rats. Cancer Res 48:2740-2743, 1988.
20. DeFlora S, Izziotti A, D'Agostini F, Balansky R, Cesorone CF. Chemopreventive properties of N-acetylcysteine and other thiols. In: Wattenberg LW, Lipkin M, Boone M, Kelloff GJ, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp 183-194, 1992.
21. McBride TJ, Preston BD, Loeb LA. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry 30:207-213, 1991.
22. Reid TM, Loeb LA. Tandem double CC→TT mutations are produced by reactive oxygen species. Proc Natl Acad Sci USA 90:3904-3907, 1993.
23. Bhimani RS, Troll W, Grunberger D, Frenkel K. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res 53:4528-4533, 1993.
24. Frenkel K, Wei H, Bhimani R, Ye J, Zaduniasky JA, Huang M-T, Ferraro T, Conney AH, Grunberger D. Inhibition of tumor promotermediated processes in mouse skin and bovine lens by CAPE. Cancer Res 53:1255-1261, 1993.
25. 2 formation and oxidative DNA damage. In: Nygaard OF, Upton AC, Eds. Anticarcinogenesis and Radiation Protection 2: Strategies in Protection from Radiation and Cancer. New York: Plenum Press, pp363-372, 1991.
26. Russo J, Russo IH. Toward a physiological approach to breast cancer chemoprevention. Cancer Epidemiol Biomarkers Prev 3:353-354, 1994.
27. Grubbs CJ, Juliana MM, Whitaker LM. Short-term hormone treatment as a chemopreventive method against mammary cancer initiation in rats. Anticancer Res. 8:113-118, 1988.
28. MacMahon B, Cole P, Lin M, Lowe CR, Mirra AP, Ravinihar B, Salber EJ, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bull World Health Organ 43:209-221, 1970.
29. Newmark HL, Lipkin M, Maheshwari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of a Western-style diet. J Natl Cancer Inst 82:491-496, 1990.
30. Khan N, Yank K, Newmark H, Wong G, Telang N, Rivlin R, Lipkin M. Mammary ductal epithelial cell hyperproliferation and hyperplasia induced by a nutritional stress diet containing four components of a Western-style diet. Carcinogenesis 15:2645-2648, 1994.
31. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB, Roth JA. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 53:4129-4133, 1993.
32. Yamamoto S, Kato R. Inhibitors of the arachidonic acid cascade and their chemoprevention of skin cancer. In: Wattenberg LW, Lipkin M, Boone M, Kelloff GJ, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp141-151, 1992.
33. Reddy BS, Rao CV, Rivenson A, Kelloff G, Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14:1493-1497, 1993.
34. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 47:5340-5346, 1987.
35. LaBayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel T, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-639, 1991.
36. Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM. Suppression of carcinogenesis in the intestines of min mice by the soy-bean-derived Bowman-Bork inhibitor. Cancer Res 56:679-682, 1996.
37. Kennedy AR. Prevention of carcinogenesis by protease inhibitors. Cancer Res 54(Suppl):1999S-2005S, 1994.
38. Shamsuddin AM, Sakamoto K. Antineoplastic action of inositol compounds: In: Wattenberg LW, Lipkin M, Boone M, Kelloff GJ, Eds. Cancer Chemoprevention. Ann Arbor, MI: CRC Press, pp285-308, 1992.
39. Wattenberg LW, Estensen RD. Studies of chemopreventive effects of myo-inositol on benzo[α]-pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis 14:1975-1977, 1993.
40. Wattenberg LW. Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J Cell Biochem Suppl 22:162-168, 1995.
41. Wattenberg LW, Estensen RD. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res 56;5132-5135, 1996.
42. Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18:1-29, 1992.
43. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. Epidemiology Cancer Causes and Control 2:325-357, 1991.
44. Silverstone H, Solomon RD, Tannenbaum A. Relative influences of natural and semipurified diets on tumor formation in mice. Cancer Res 12:750-757, 1952.
45. Hecht SS, Shantu MA, Stoner GD, Jordan KG, Choi C-I, Chung F-L. Rapid single-dose model for tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-t-butanone and the effect of diet. Carcinogenesis 10:1901-1904, 1989.
46. El-Bayoumy K. Evaluation of chemopreventive agents against breast cancer and proposed strategies for fugure clinical intervention trials. Carcinogenesis 15:2395-2420, 1994.
47. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher E, Margolese R, Robidoux A, Shibata H, Terz J, Patterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, Ketner M. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484, 1989.
48. Jordan VC. An overview of considerations for the testing of tamoxifen as a preventive for breast cancer. Ann N Y Acad Sci 768:141-147, 1995.
49. Gould MN. Prevention and therapy of mammary cancer by monoterpenes. J Cell Biochem Suppl 22:139-144, 1995.
50. Crowell PL, Kennan WS, Haag JD, Ahmad S, Vedejs E, Gould MN. Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene. Carcinogenesis 13:1261-1264, 1992.
51. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-1574, 1991.
52. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 86:1403-1408, 1994.
53. Karp E, Chirada A, Brawley O, Kelloff G. Prostate cancer prevention: Investigational approaches and opportunities. Cancer Res 56:5547-5556, 1996.
54. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. Metastic prostate cancer in a transgenic mouse. Cancer Res 56:5547-5556, 1996.
55. Greenberg NM, DeMayo F, Finegold M, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Marusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443, 1995.
56. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention in women. Science 259:633-636, 1993.
57. Reeves MJ, Newcomb PA, Dietz AT, Stoner BE, Remington PL. Nonsteroidal antiinflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 5:955-960, 1996.
58. Greenberg ER, Baron JA. Prospects for preventing colorectal cancer deaths. J Natl Cancer Inst 85:1182-1184, 1993.
59. Paganini-Hill A, Chao A, Ross R, Henderson B. Aspirin use and chronic disease, a cohort study of the elderly. Br Med J 299:1247-1250, 1989.
60. Pastorino U, Infante M, Maoli M, Chieso G, Buyse M, Firket P, Rosementz N, Clerici M, Soresi E, Valente M, Belloni P, Ravasi G. Adjuvant treatment of Stage I lung cancer with high-dose vitamin A. J Clin Oncol 11:1216-1222, 1993.
61. Lippman S, Benner, Hong W-K. Retinoid Chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res 54(Suppl):2025S-2028S, 1994.
62. Komori A, Yatsunami J, Okabe S, Abe S, Hara K, Suganama M, Kim S-J, Fujiki H. Anticarcinogenic activity of green tea polyphenols. Jpn J Clin Oncol 23:186-190, 1993.
63. Wang ZY, Wang L-D, Lee M-J, Ho C-T, Huang M-T, Conney AH, Yang CS. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 16:2143-2148, 1995.
64. Yamane T, Takahashi T, Kutwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H. Inhibition of N-methyl-N′-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55:2081-2084, 1995.
65. Conney AH, Lysz T, Ferraro T, Abidi TF, Marchand PS, Laskin JD, Huang M-T. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31:385-396, 1991.
66. Ip C, Hayes C, Budnick RM, Ganther HE. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res 51:595-600, 1991.
67. Clark LC, Combs GF, Turnbull BW, Slate EH, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. JAMA 276:1957-1963, 1996.
68. Tannenbaum A, Silverstone H. Nutrition in relationship to cancer. Adv Cancer Res 1:451-501, 1953.
69. Hamada N, Engelman RW, Tomita Y, Chen R-F, Iwai H, Good RA, Day NK. Prolactin effects on the dietary regulation of mouse mammary tumor virus proviral DNA expression. Proc Natl Acad Sci U S A 87:6733-6737, 1990.
70. Pashko LL, Schwartz AG. Inhibition of 7,12-dimethylbenz[a]anthracene-induced lung tumorigenesis in A/J mice by food restriction is reversed by adrenalectomy. Carcinogenesis 17:209-212, 1996.